The safety and efficacy of ARN inhibitors in patients following MI was investigated in the PARADISE-MI (Prospective ARN Inhibitor vs ACE Inhibitor Trial to Determine Superiority in Reducing HF Events After MI).61 The gene discussed is ACE; the disease is hydrops fetalis.